A detailed history of Meros Investment Management, LP transactions in Biolife Solutions Inc stock. As of the latest transaction made, Meros Investment Management, LP holds 173,910 shares of BLFS stock, worth $4.76 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares
173,910
Previous 399,803 56.5%
Holding current value
$4.76 Million
Previous $8.57 Million 49.2%
% of portfolio
2.02%
Previous 4.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

SELL
$19.19 - $26.52 $4.33 Million - $5.99 Million
-225,893 Reduced 56.5%
173,910 $4.35 Million
Q2 2024

Aug 15, 2024

BUY
$15.14 - $22.99 $99,712 - $151,412
6,586 Added 1.67%
399,803 $8.57 Million
Q1 2024

May 15, 2024

BUY
$15.35 - $18.82 $15,334 - $18,801
999 Added 0.25%
393,217 $7.29 Million
Q4 2023

Feb 14, 2024

BUY
$8.99 - $16.86 $179,934 - $337,452
20,015 Added 5.38%
392,218 $6.37 Million
Q3 2023

Nov 14, 2023

BUY
$10.81 - $22.96 $515,896 - $1.1 Million
47,724 Added 14.71%
372,203 $5.14 Million
Q2 2023

Aug 11, 2023

BUY
$17.19 - $24.34 $1.71 Million - $2.43 Million
99,711 Added 44.36%
324,479 $7.17 Million
Q1 2023

May 16, 2023

BUY
$17.67 - $26.07 $152,827 - $225,479
8,649 Added 4.0%
224,768 $4.89 Million
Q4 2022

Feb 14, 2023

BUY
$16.95 - $25.07 $1.24 Million - $1.84 Million
73,261 Added 51.28%
216,119 $3.93 Million
Q3 2022

Nov 14, 2022

SELL
$14.64 - $26.7 $816,619 - $1.49 Million
-55,780 Reduced 28.08%
142,858 $3.25 Million
Q2 2022

Aug 12, 2022

BUY
$10.54 - $24.2 $1.58 Million - $3.63 Million
150,134 Added 309.53%
198,638 $2.74 Million
Q1 2022

May 13, 2022

BUY
$20.81 - $37.29 $478,817 - $858,005
23,009 Added 90.25%
48,504 $1.1 Million
Q4 2021

Feb 16, 2022

BUY
$32.99 - $58.55 $841,080 - $1.49 Million
25,495 New
25,495 $950,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.17B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Meros Investment Management, LP Portfolio

Follow Meros Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meros Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Meros Investment Management, LP with notifications on news.